Monday, January 12, 2004 1:16:39 PM
The question is simple. Are you saying the Orchid option has run out or not in regards to Retinome?
-The window starts when IP is presented by DNAP.
-IP usually refers to issued patents.
-DNAP has no patents issued yet.
The question is clear, the assumptions are straightforward. What is the problem?
regards,
frog
p.s. Don't worry about my life, I'm fine. I and my colleagues design and develop lifesaving medical devices that intervene in life threatening situations. There are thousands of people walking this earth today who wouldn't be if not for our efforts. I have no problems with my life choices. Good luck with yours.
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM